Drugs / PegINFα-2
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT04382339 Comparator | Mar → Nov 2015 | chronic hepatitis C virus infection | Beni-Suef University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PegINFα-2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04382339 ↗ |
| Modality | Protein / enzyme biologic | “PegINFα-2: chemically modified form of the standard interferon that treats hepatitis C” NCT04382339 ↗ |